Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
0.960
+0.033 (3.57%)
Mar 11, 2025, 4:00 PM EST - Market closed
Fate Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 13.63 | 63.53 | 96.3 | 55.85 | 31.43 | Upgrade
|
| Revenue Growth (YoY) | -78.55% | -34.03% | 72.44% | 77.66% | 194.33% | Upgrade
|
| Cost of Revenue | 118.53 | 157.19 | 320.45 | 215.52 | 125.62 | Upgrade
|
| Gross Profit | -104.9 | -93.65 | -224.15 | -159.67 | -94.19 | Upgrade
|
| Selling, General & Admin | 90.64 | 96.86 | 84.23 | 57.32 | 33.9 | Upgrade
|
| Operating Expenses | 90.64 | 96.86 | 84.23 | 57.32 | 33.9 | Upgrade
|
| Operating Income | -195.54 | -190.51 | -308.39 | -216.99 | -128.09 | Upgrade
|
| Interest & Investment Income | 17.29 | 17.19 | 5.84 | 1.31 | 2.4 | Upgrade
|
| Other Non Operating Income (Expenses) | 6.73 | 7.3 | 20.32 | 3.53 | -47.7 | Upgrade
|
| EBT Excluding Unusual Items | -171.53 | -166.03 | -282.22 | -212.15 | -173.39 | Upgrade
|
| Asset Writedown | -14.74 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | 5.1 | 0.5 | - | - | Upgrade
|
| Pretax Income | -186.26 | -160.93 | -281.72 | -212.15 | -173.39 | Upgrade
|
| Net Income | -186.26 | -160.93 | -281.72 | -212.15 | -173.39 | Upgrade
|
| Net Income to Common | -186.26 | -160.93 | -281.72 | -212.15 | -173.39 | Upgrade
|
| Shares Outstanding (Basic) | 114 | 98 | 97 | 95 | 82 | Upgrade
|
| Shares Outstanding (Diluted) | 114 | 98 | 97 | 95 | 82 | Upgrade
|
| Shares Change (YoY) | 15.52% | 1.64% | 2.19% | 15.01% | 20.82% | Upgrade
|
| EPS (Basic) | -1.64 | -1.64 | -2.91 | -2.24 | -2.10 | Upgrade
|
| EPS (Diluted) | -1.64 | -1.64 | -2.91 | -2.24 | -2.10 | Upgrade
|
| Free Cash Flow | -123.6 | -138.42 | -283.77 | -213.57 | -44.16 | Upgrade
|
| Free Cash Flow Per Share | -1.09 | -1.41 | -2.93 | -2.25 | -0.54 | Upgrade
|
| Gross Margin | - | -147.41% | -232.77% | -285.92% | -299.64% | Upgrade
|
| Operating Margin | -1434.52% | -299.86% | -320.23% | -388.56% | -407.47% | Upgrade
|
| Profit Margin | -1366.46% | -253.30% | -292.55% | -379.89% | -551.59% | Upgrade
|
| Free Cash Flow Margin | -906.79% | -217.86% | -294.68% | -382.43% | -140.49% | Upgrade
|
| EBITDA | -176.58 | -172.23 | -294.63 | -211.14 | -125 | Upgrade
|
| EBITDA Margin | - | -271.09% | - | - | - | Upgrade
|
| D&A For EBITDA | 18.96 | 18.28 | 13.76 | 5.85 | 3.09 | Upgrade
|
| EBIT | -195.54 | -190.51 | -308.39 | -216.99 | -128.09 | Upgrade
|
| EBIT Margin | - | -299.86% | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.